For the third year in a row, DISA Global Solutions is hosting its annual Day with DISA conference and networking event, one of the largest employee screening events in the U.S. This year, we’ve decided to move the event to a virtual format to ensure the health and safety of all attendees, customers, and employees. Free to attend, we’ve expanded to 16 sessions over four days! Industry-leading experts will present each of our employee screening sessions with live interactive Q&A’s, door prizes, and more. Registration opens on 10/01!
Each year DISA grows our list of attendees, including over 800 HR and Safety employees across several safety-sensitive industries, including Oil & Gas, Chemical, and Transportation in 2019 alone! As we head into new territory on a virtual platform, we’re anticipating an even larger audience with more one-on-one ways to chat with DISA experts, industry leaders, and our speakers themselves. Choose from 16 sessions ranging from six different categories, including Drug Testing, Backgrounds, Transportation, Occupational Health, Energy Owner/Operators, and DISA.
The Department of Transportation, understandably, creates strict guidelines for its employees relating to workplace safety that continue to change with regard to the evolution of drug use. Although marijuana, in certain states, and prescription drugs are legal, the DOT regulations remain stringent. This session will cover the significant updates in DOT regulations. We will address the issue of use vs abuse, along with the age of prescriptions, and a review of safety concerns from the MRO. Additionally, we will discuss the Medical Disclosure policies for both DOT and non-DOT.
The effects of marijuana on the general population are difficult to define. Marijuana is unregulated, making it especially complex for consumers to know what they are getting and for law officials to determine a level of impairment. Emerging technology is paving the way to get a better understanding of impairment levels. This session will cover the issue of impairment in the workplace and on the road, and an overview of marijuana since recreational legalization including ER visits, accidents, and the increase in potency. It will also address the new technological advancements and the legislative hurdles that are associated.
As an employer facing new marijuana laws, you might feel the pressure of protecting your company and employees more than ever before. We hope to relieve some of the weight on your shoulders by providing helpful information. Nina French will guide us through an over view of marijuana legalization in the U.S. the issue it presents to employers and the current status. We will review the list of proposed laws and what's to come, and additionally we will discuss how employers can take action with drug testing policies.
will also present an in-depth analysis of DISA's second annual 2019 Owners Survey, an annual survey of more than 60 industrial owner/operators on drug testing trends in the safety sensitive, industrial market.
Hair testing uniquely reveals a wealth of information about drug use over a period of time by analyzing sections of a small hair sample. As the hair testing pioneer and leader for oil and gas companies and contractors, Psychemedics gleans insights from the deepest dataset in the industry to gauge trends. In this session, we will present real workplace data that details positive rates for marijuana, and both pre and post MRO review results. We will also compare and contrast with other industries and deliver insights the most effective detection and deterrence strategies.
Although marijuana is illegal on the federal level, many states have chosen to legalize either medical, recreational or both. The list of states who choose to legalize is steadily growing, each with different protocol, making it extremely difficult to stay up-to-date. This session will give an overview of marijuana legalization in the US and the issue it presents to employers and the current status. We will address a list of proposed laws and what that could mean. Find out how to terminate employees that are using and the legal responsibilities for employers, along with best practices. We will review important cases and the implications for employers and include the Americans with Disabilities Act (ADA) as it relates to recreational and medical marijuana.
Today's fragmented, fast-paced, evolving business environment requires a proactive compliance/legal program to support your business. This session will explore how developing and implementing a proactive program helps you avoid difficulties by bringing your compliance/legal program front and center as a cornerstone of your employee testing.
The complexity surrounding marijuana laws and employer responsibilities can be daunting, but we aim to leave you informed and confident to carry out a program that will benefit your workplace and protect both your company and employees. In this session Nina French and Frank Bernard, both equipped with a vast knowledge of employee screening and compliance, will review the types of drug testing laws, and policy of best practices. You will also learn the impact of DOT/HHS/SAMSHA on state laws.